R
Robert Levy
Guest
Anouncement:
Doug London will be giving a lecture on Oct 1st, at 7 pm at the Plymouth library on Omega 3's and
their use in treating Mental illness.
Douglas S. London Douglas London is on the faculty of medicine at Harvard Medical School. London is
a Research Associate at the Psychopharmacological Research Laboratory at Mclean Hospital and works
with Andrew Stoll, MD, on novel treatments, particularly those that are most promising for
developing nations and populations in the US that do not have access to traditional pharmacological
medications and therapies. He is Executive Director of BrainRights for the Americas (Mente Sana para
las Americas). He was director of the International Psychiatric Clinic (Clinica Internacional para
la Ansiedad) in Antigua, Guatemala and is present director of the International Psychiatric Clinic
in Honduras. He has worked for 15 years in developing nations in Africa and Latin America. London
has worked for a variety of institutions including United States government programs, the United
Nations, international non-governmental organizations and research institutions. He has established
new hospitals in the developing world such as a general hospital in Angola, Africa, building the
physical resources, training hospital staff and administering the hospital until it was running
smoothly. London has also founded and served as director for a research mental health clinic in
Central America. He has trained doctors and medical staff in aspects of psychopharmacology in
hospitals in Central America. London has done research in
psychopharmacology in the developing world including the use of omega-3 fatty acids in pediatric and
adult affective disorder in Guatemala and is a pioneer in the field of agricultural psychiatry.
Doug London will be giving a lecture on Oct 1st, at 7 pm at the Plymouth library on Omega 3's and
their use in treating Mental illness.
Douglas S. London Douglas London is on the faculty of medicine at Harvard Medical School. London is
a Research Associate at the Psychopharmacological Research Laboratory at Mclean Hospital and works
with Andrew Stoll, MD, on novel treatments, particularly those that are most promising for
developing nations and populations in the US that do not have access to traditional pharmacological
medications and therapies. He is Executive Director of BrainRights for the Americas (Mente Sana para
las Americas). He was director of the International Psychiatric Clinic (Clinica Internacional para
la Ansiedad) in Antigua, Guatemala and is present director of the International Psychiatric Clinic
in Honduras. He has worked for 15 years in developing nations in Africa and Latin America. London
has worked for a variety of institutions including United States government programs, the United
Nations, international non-governmental organizations and research institutions. He has established
new hospitals in the developing world such as a general hospital in Angola, Africa, building the
physical resources, training hospital staff and administering the hospital until it was running
smoothly. London has also founded and served as director for a research mental health clinic in
Central America. He has trained doctors and medical staff in aspects of psychopharmacology in
hospitals in Central America. London has done research in
psychopharmacology in the developing world including the use of omega-3 fatty acids in pediatric and
adult affective disorder in Guatemala and is a pioneer in the field of agricultural psychiatry.